UK NSC Recommendations
This list summarises whether population screening is currently recommended for a condition or not, and if it is open to public comments at this time.
Recommendations are reviewed regularly, usually every 3 years. Use the filters to read the details of the findings and supporting documents from the most recent review.
Showing 1 – 20 of 32 results
| Condition | Who it affects | Screening recommended | Public comments |
|---|---|---|---|
| ALD | Newborn | Not recommended | |
| Amino acid metabolism disorders | Newborn | Not recommended | |
| Biliary atresia | Newborn | Not recommended | |
| Biotinidase deficiency | Newborn | Not recommended | |
| Congenital adrenal hyperplasia | Newborn | Not recommended | |
| Congenital cataracts | Newborn | Recommended | |
| Congenital heart disease | Newborn | Recommended | |
| Congenital hypothyroidism | Newborn | Recommended | |
| Cryptorchidism | Newborn | Recommended | |
| Cystic fibrosis (newborn) | Newborn | Recommended | |
| Developmental dislocation of the hip | Newborn | Recommended | |
| Duchenne muscular dystrophy | Newborn | Not recommended | |
| Fatty-acid oxidation disorders | Newborn | Not recommended | |
| FMAIT | Antenatal, Newborn | Not recommended | |
| GA1 | Newborn | Recommended | |
| Galactosaemia | Newborn | Not recommended | |
| Gaucher disease | Newborn | Not recommended | |
| HCU | Newborn | Recommended | |
| Hearing (newborn) | Newborn | Recommended | |
| IVA | Newborn | Recommended |